Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomerica (BMRA) Revenue (2016 - 2025)

Biomerica's Revenue history spans 16 years, with the latest figure at $1.2 million for Q4 2025.

  • For Q4 2025, Revenue fell 26.04% year-over-year to $1.2 million; the TTM value through Nov 2025 reached $4.5 million, down 20.07%, while the annual FY2025 figure was $5.3 million, 1.92% down from the prior year.
  • Revenue for Q4 2025 was $1.2 million at Biomerica, down from $1.4 million in the prior quarter.
  • Across five years, Revenue topped out at $7.7 million in Q1 2022 and bottomed at $749000.0 in Q2 2025.
  • The 5-year median for Revenue is $1.4 million (2022), against an average of $2.1 million.
  • The largest annual shift saw Revenue soared 402.99% in 2022 before it crashed 85.5% in 2023.
  • A 5-year view of Revenue shows it stood at $4.6 million in 2021, then crashed by 68.11% to $1.5 million in 2022, then rose by 5.74% to $1.6 million in 2023, then increased by 4.4% to $1.6 million in 2024, then decreased by 26.04% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for BMRA's Revenue are $1.2 million (Q4 2025), $1.4 million (Q3 2025), and $749000.0 (Q2 2025).